Domestic

(Reuters) -The U.S. Food and Drug Administration on Thursday announced a new program to speed up construction and review of drug manufacturing plants in the country to boost domestic drug supply. The program, called FDA PreCheck, aims to streamline review of domestic pharmaceutical plants and eliminate unnecessary regulatory requirements, in line with President Donald Trump’s…

By Deena Beasley and Julie Steenhuysen (Reuters) -The U.S. Food and Drug Administration on Wednesday approved Gilead Sciences lenacapavir, a twice-yearly injection, for preventing HIV infection in adults and adolescents. Gilead said the drug will be sold under the brand name Yeztugo. Investors and AIDS activists had been eagerly awaiting the regulatory decision for a…